- Facial Acne Vulgaris Improved With Sarecycline Among Patients of Color
- In Prurigo Nodularis, Dupilumab Achieves Clinically Meaningful Improvement
- Ruxolitinib Cream Improves, Stabilizes Total Vitiligo Area Scoring Index
- Skin Cancer Risk Is Higher in Patients With Atopic Dermatitis
- Deuruxolitinib Shows Promise for Treating Alopecia Areata
- Moderate to Severe Psoriasis Symptoms Improved With Anti-IL-17A Biologics
- Alopecia Areata Significantly Associated With Various Inflammatory Arthropathies
- Skin Cancer Care Delays Influenced by Low Income, Insurance Barriers
- New Atopic Dermatitis Algorithm Matches FDA-Approved Treatment to Patient
- Secukinumab Improves Hidradenitis Suppurativa Without Systemic Antibiotics
- Increase in Perioral Dermatitis May Be Linked to Mask Use During COVID-19 Pandemic
- Biologics May Reduce Psoriatic Arthritis Development in Patients With Psoriasis
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Kidney Transplant Recipients Do Not Benefit From Infliximab Induction
Ensitrelvir Demonstrates Rapid Antiviral Efficacy Against COVID-19 in Phase 2b Trial
Post-COVID-19 Conditions Tied to Higher Health Care Utilization
Cigarette Smoking Leads to More Rapid Lung Function Decline in Patients With HIV
CDC Investigating Artificial Tears Product Linked to Drug-Resistant Infections
